Air Force releases guidance on use of cloth face covers

Secretary of the Air Force Public Affairs / Published April 06, 2020

ARLINGTON, Va. (AFNS) – To help combat COVID-19, the Air Force has released information that supplements Department of Defense guidance on the use of cloth face coverings, effective immediately.

To the extent practical, without significantly impacting mission, all individuals on Department of the Air Force property, installations and facilities are required to wear cloth face coverings when they cannot maintain six feet of physical distance in public areas or work centers.

This guidance applies to Total Force military personnel, DOD civilian employees and contractors, family members and all individuals on DAF property, installations and facilities, and does not apply within a personal residence on a military installation.

Any cloth items worn as face coverings (e.g., neck gaiters, neck warmers, balaclavas, etc.) should be functional, cleaned and maintained in compliance with current Air Force instructions, and should cover the mouth and nose.

As safety is the primary concern, commanders will decide where mission safety necessitates deviation from this guidance, for example when the cloth face covering could interfere with other facial gear. Until issued items are fully available, commanders and units may deviate in regard to uniformity while ensuring face coverings worn by uniformed military members are conservative, professional and in keeping with dignity and respect.

For civilian employees, use of a cloth face covering is strongly encouraged. Commanders who wish to mandate cloth face covering for civilian employees under this memo must either furnish them or provide a uniform allowance per AFI 36-128, Pay Setting and Allowances, published May 17, 2019.

If a commander determines the purchase and issuance of cloth face coverings is necessary for mission requirements, they should consult with legal and comptroller about purchasing and issuing the coverings.

N95 and surgical masks should be reserved for health care workers.

During this time, security checkpoints may require the lowering of masks to verify identification.

It is to be noted that the use of a cloth face covering does not prevent the wearer from getting sick or eliminate the need to continue the primary mitigation efforts to stop the spread of COVID-19, but may prevent the spread of the virus from the wearer to others.

For more information on COVID-19 visit https://www.af.mil/News/Coronavirus-disease-2019

https://www.af.mil/News/Article-Display/Article/2138804/air-force-releases-guidance-on-use-of-cloth-face-covers/fbclid/IwAR0XraekNTd71JryKR1ivzKw1lCaf5UpAZn9aMTSSCWTAQ09kl8YL3jd9Ys/

>>8704510

From their website. Seems they've learned how to counter any know resistance to WormWood by malaria.

Increase the course of treatment from 3 to 7 days.

http://www.asclepius-biotech.com/news/a-breakthrough-in-artemisinin-resistance-24652124.html

A Breakthrough In Artemisinin Resistance

Jun 26, 2019

On June 17, according to major media reports, Tu Youyou, a Chinese female scientist, and her team made a breakthrough in the problem of artemisinin resistance through in-depth study of the mechanism of malaria resistance. Over three years of scientific research, Tu Youyou's team combines anti-malarial treatment methods with the causes of drug resistance, and proposes the latest treatment options:

One is to prolong the medication time from three days to five or seven days, and the other is to replace the adjuvant drugs that have produced resistance in artemisinin combination therapy, with immediate effect.

Several studies from WHO and Southeast Asian countries have shown that in Cambodia, Thailand, Myanmar, Vietnam and other Mekong region countries, the three-day cycle of artemisinin combination therapy for malaria-infected patients shows signs of slow elimination of malaria parasites and resistance to artemisinin. The World Malaria Report 2018 predicts a 40% reduction in malaria infection and mortality by 2020. Therefore, it is urgent to break through artemisinin resistance.

However, Tu Youyou team expert Wang Gang pointed out that artemisinin is still effective in the treatment of malaria, and does not show complete resistance, but requires a longer course of treatment or other adjustments to the combined treatment regimen. He further pointed out that the next generation of antimalarials superior to artemisinins in efficacy, safety and risk of drug resistance is unlikely to emerge in a short time. Therefore, Tu Youyou's team's reasonable plan of "artemisinin resistance" is not "breakthrough", but "progress".

Learn more

Artemenisin = Wormwood = Thujone

http://www.asclepius-biotech.com/news/a-breakthrough-in-artemisinin-resistance-24652124.html

A Breakthrough In Artemisinin Resistance

Jun 26, 2019

On June 17, according to major media reports, Tu Youyou, a Chinese female scientist, and her team made a breakthrough in the problem of artemisinin resistance through in-depth study of the mechanism of malaria resistance. Over three years of scientific research, Tu Youyou's team combines anti-malarial treatment methods with the causes of drug resistance, and proposes the latest treatment options:

One is to prolong the medication time from three days to five or seven days, and the other is to replace the adjuvant drugs that have produced resistance in artemisinin combination therapy, with immediate effect.

Several studies from WHO and Southeast Asian countries have shown that in Cambodia, Thailand, Myanmar, Vietnam and other Mekong region countries, the three-day cycle of artemisinin combination therapy for malaria-infected patients shows signs of slow elimination of malaria parasites and resistance to artemisinin. The World Malaria Report 2018 predicts a 40% reduction in malaria infection and mortality by 2020. Therefore, it is urgent to break through artemisinin resistance.

However, Tu Youyou team expert Wang Gang pointed out that artemisinin is still effective in the treatment of malaria, and does not show complete resistance, but requires a longer course of treatment or other adjustments to the combined treatment regimen. He further pointed out that the next generation of antimalarials superior to artemisinins in efficacy, safety and risk of drug resistance is unlikely to emerge in a short time. Therefore, Tu Youyou's team's reasonable plan of "artemisinin resistance" is not "breakthrough", but "progress".

Learn more